US 12258412
Nucleic acid molecules encoding bispecific anti-BCMA x anti-CD3 antibodies
granted A61KA61K2239/31A61K2239/38
Quick answer
US patent 12258412 (Nucleic acid molecules encoding bispecific anti-BCMA x anti-CD3 antibodies) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2239/31, A61K2239/38, A61K2239/48, A61K40/11